BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3542501)

  • 61. Effects of cell volume on insulin binding, internalization and degradation in rat adipocytes.
    Flint DJ; Gardner MJ
    Mol Cell Endocrinol; 1984 Jul; 36(3):229-36. PubMed ID: 6381172
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Shunting of insulin from a retroendocytotic pathway to a degradative pathway by sodium vanadate.
    Marshall S; Garvey WT; Monzon R
    J Biol Chem; 1987 Sep; 262(25):12005-12. PubMed ID: 3305500
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Internalization and degradation of a low affinity insulin ([LeuB24]insulin) by rat adipocytes.
    Green A; Tager H; Rubenstein A; Frank B; Olefsky JM
    FEBS Lett; 1982 Aug; 144(2):255-8. PubMed ID: 6749549
    [No Abstract]   [Full Text] [Related]  

  • 64. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP; Peavy DE; Frank BH; Duckworth WC
    Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes.
    Jochen A; Berhanu P
    Biochem Biophys Res Commun; 1987 Jan; 142(1):205-12. PubMed ID: 3545203
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood.
    Benzi L; Cecchetti P; Ciccarone A; Pilo A; Di Cianni G; Navalesi R
    Diabetes; 1994 Feb; 43(2):297-304. PubMed ID: 8288054
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Insulin binding to erythrocytes incubated in vitro at physiological temperature.
    Freidenberg GF; Kao M; Olefsky JM
    J Clin Endocrinol Metab; 1983 Jul; 57(1):107-14. PubMed ID: 6343415
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence for an early degradative event to the insulin molecule following binding to hepatocyte receptors.
    Juul SM; Jones RH; Evans JL; Neffe J; Sönksen PH; Brandenburg D
    Biochim Biophys Acta; 1986 Apr; 856(2):310-9. PubMed ID: 3513837
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Insulin degradation into monocytes from normal subjects: a high performance liquid chromatographic analysis.
    Benzi L; Marchetti P; Brunetti A; Ciccarone AM; Cecchetti P; Trischitta E; Di Cianni G; Squatrito S; Navalesi R
    J Endocrinol Invest; 1988 Apr; 11(4):303-7. PubMed ID: 3045192
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stoichiometric translocation of adipocyte insulin receptors from the cell-surface to the cell-interior. Studies using a novel method to rapidly remove detergent and concentrate soluble receptors.
    Marshall S; Heidenreich KA; Horikoshi H
    J Biol Chem; 1985 Apr; 260(7):4128-35. PubMed ID: 3884606
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insulin degradation by adipose tissue. Studies at several levels of cellular organization.
    Goldstein BJ; Livingston JN
    Biochem J; 1980 Jan; 186(1):351-60. PubMed ID: 6445191
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HPLC analysis of insulin degradation products from isolated hepatocytes. Effects of inhibitors suggest intracellular and extracellular pathways.
    Hamel FG; Peavy DE; Ryan MP; Duckworth WC
    Diabetes; 1987 Jun; 36(6):702-8. PubMed ID: 3552802
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of bacitracin on binding and processing of insulin by established renal cell line.
    Yagil C; Frank BH; Rabkin R
    Diabetes; 1988 Jun; 37(6):800-5. PubMed ID: 3290001
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification.
    Hamel FG; Mahoney MJ; Duckworth WC
    Diabetes; 1991 Apr; 40(4):436-43. PubMed ID: 2010043
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence that bacitracin alters intracellular insulin metabolism in isolated rat hepatocytes.
    Peavy DE; Hamel FG; Kincke VL; Duckworth WC
    Diabetes; 1985 Mar; 34(3):217-21. PubMed ID: 3882488
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
    Sato H; Tsuji A; Hirai K; Kang YS
    Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Renal uptake and degradation of trapped-label insulin.
    Hysing J; Tolleshaug H; Kindberg GM
    Ren Physiol Biochem; 1989; 12(4):228-37. PubMed ID: 2694244
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insulin processing by the liver.
    Caro JF; Muller G; Glennon JA
    J Biol Chem; 1982 Jul; 257(14):8459-66. PubMed ID: 7045123
    [No Abstract]   [Full Text] [Related]  

  • 79. Differences in the cellular processing of AspB10 human insulin compared with human insulin and LysB28ProB29 human insulin.
    Hamel FG; Siford GL; Fawcett J; Chance RE; Frank BH; Duckworth WC
    Metabolism; 1999 May; 48(5):611-7. PubMed ID: 10337862
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evidence for a direct effect of bacitracin on cell-mediated insulin degradation in isolated hepatocytes.
    Juul SM; Jones RH
    Biochem J; 1982 Aug; 206(2):295-9. PubMed ID: 6756390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.